Background: Metabolic dysfunction-associated steatotic liver disease (MALSD) is a recent classification that better reflects the cardiometabolic factors contributing to the condition, while reducing stigma associated with previous terminology. Characterized by triglyceride accumulation, MALSD can progress to inflammation and fibrosis if untreated. Although the FIB-4 score is commonly used to assess liver fibrosis, its association with [...]